FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206291223> ?p ?o ?g. }

• W4206291223 abstract "In sickle cell disease (SCD), the pathological shift of red blood cells (RBCs) into distorted morphologies under hypoxic conditions follows activation of a cationic leak current (Psickle) and cell dehydration. Prior work showed sickling was reduced by 5-hydroxylmethyl-2-furfural (5-HMF), which stabilized mutant hemoglobin and also blocked the Psickle current in RBCs, though the molecular basis of this 5-HMF-sensitive cation current remained a mystery. Work here is the first to test the hypothesis that Aquaporin-1 (AQP1) cation channels contribute to the monovalent component of Psickle. Human AQP1 channels expressed in Xenopus oocytes were evaluated for sensitivity to 5-HMF and four derivatives known to have differential efficacies in preventing RBC sickling. Ion conductances were measured by two-electrode voltage clamp, and osmotic water permeability by optical swelling assays. Compounds tested were: 5-HMF; 5-PMFC (5-(phenoxymethyl)furan-2-carbaldehyde); 5-CMFC (5-(4-chlorophenoxymethyl)furan-2-carbaldehyde); 5-NMFC (5-(2-nitrophenoxymethyl)-furan-2-carbaldehyde); and VZHE006 (tert-butyl (5-formylfuran-2-yl)methyl carbonate). The most effective anti-sickling agent, 5-PMFC, was the most potent inhibitor of the AQP1 ion conductance (98% block at 100 µM). The order of sensitivity of the AQP1 conductance to inhibition was 5-PMFC > VZHE006 > 5-CMFC ≥ 5-NMFC, which corresponded with effectiveness in protecting RBCs from sickling. None of the compounds altered AQP1 water channel activity. Combined application of a selective AQP1 ion channel blocker AqB011 (80 µM) with a selective hemoglobin modifying agent 5-NMFC (2.5 mM) increased anti-sickling effectiveness in red blood cells from human SCD patients. Another non-selective cation channel known to be expressed in RBCs, Piezo1, was unaffected by 2 mM 5-HMF. Results suggest that inhibition of AQP1 ion channels and capacity to modify hemoglobin are combined features of the most effective anti-sickling agents. Future therapeutics aimed at both targets could hold promise for improved treatments for SCD." @default.
• W4206291223 created "2022-01-26" @default.
• W4206291223 creator A5006530180 @default.
• W4206291223 creator A5024977714 @default.
• W4206291223 creator A5032441791 @default.
• W4206291223 creator A5036795263 @default.
• W4206291223 creator A5044436273 @default.
• W4206291223 creator A5056794307 @default.
• W4206291223 creator A5058099278 @default.
• W4206291223 creator A5076574432 @default.
• W4206291223 creator A5079691100 @default.
• W4206291223 date "2022-01-17" @default.
• W4206291223 modified "2023-09-30" @default.
• W4206291223 title "Inhibition of the Aquaporin-1 Cation Conductance by Selected Furan Compounds Reduces Red Blood Cell Sickling" @default.
• W4206291223 cites W1499254173 @default.
• W4206291223 cites W1568380576 @default.
• W4206291223 cites W178431745 @default.
• W4206291223 cites W1936238841 @default.
• W4206291223 cites W1974769027 @default.
• W4206291223 cites W1979856671 @default.
• W4206291223 cites W1981313964 @default.
• W4206291223 cites W1983940797 @default.
• W4206291223 cites W1984284559 @default.
• W4206291223 cites W1991470912 @default.
• W4206291223 cites W1998802474 @default.
• W4206291223 cites W1999720993 @default.
• W4206291223 cites W2001613505 @default.
• W4206291223 cites W2003879331 @default.
• W4206291223 cites W2015929262 @default.
• W4206291223 cites W2016490468 @default.
• W4206291223 cites W2023821031 @default.
• W4206291223 cites W2027816595 @default.
• W4206291223 cites W2031638883 @default.
• W4206291223 cites W2051009040 @default.
• W4206291223 cites W2053495832 @default.
• W4206291223 cites W2053977404 @default.
• W4206291223 cites W2054887228 @default.
• W4206291223 cites W2058156281 @default.
• W4206291223 cites W2062856652 @default.
• W4206291223 cites W2066473104 @default.
• W4206291223 cites W2066500575 @default.
• W4206291223 cites W2070088403 @default.
• W4206291223 cites W2071803108 @default.
• W4206291223 cites W2073487012 @default.
• W4206291223 cites W2077601502 @default.
• W4206291223 cites W2102819228 @default.
• W4206291223 cites W2104989250 @default.
• W4206291223 cites W2115870516 @default.
• W4206291223 cites W2134967712 @default.
• W4206291223 cites W2135811187 @default.
• W4206291223 cites W2138461591 @default.
• W4206291223 cites W2145731224 @default.
• W4206291223 cites W2147792416 @default.
• W4206291223 cites W2150283931 @default.
• W4206291223 cites W2167079285 @default.
• W4206291223 cites W2172108250 @default.
• W4206291223 cites W2174561121 @default.
• W4206291223 cites W2176899340 @default.
• W4206291223 cites W2285115828 @default.
• W4206291223 cites W2301678655 @default.
• W4206291223 cites W2322453619 @default.
• W4206291223 cites W2335076886 @default.
• W4206291223 cites W2402701121 @default.
• W4206291223 cites W2406440068 @default.
• W4206291223 cites W2410198113 @default.
• W4206291223 cites W2470221163 @default.
• W4206291223 cites W2750801151 @default.
• W4206291223 cites W2765497308 @default.
• W4206291223 cites W2766786653 @default.
• W4206291223 cites W2775715295 @default.
• W4206291223 cites W2802443283 @default.
• W4206291223 cites W2922454853 @default.
• W4206291223 cites W2927682716 @default.
• W4206291223 cites W2978278087 @default.
• W4206291223 cites W2978309986 @default.
• W4206291223 cites W2981666196 @default.
• W4206291223 cites W2987121884 @default.
• W4206291223 cites W2987175056 @default.
• W4206291223 cites W2991286242 @default.
• W4206291223 cites W3027415864 @default.
• W4206291223 cites W3092453145 @default.
• W4206291223 cites W3126842523 @default.
• W4206291223 cites W3146085001 @default.
• W4206291223 cites W4211186710 @default.
• W4206291223 cites W4241014990 @default.
• W4206291223 cites W4252915745 @default.
• W4206291223 cites W800350851 @default.
• W4206291223 doi "https://doi.org/10.3389/fphar.2021.794791" @default.
• W4206291223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35111062" @default.
• W4206291223 hasPublicationYear "2022" @default.
• W4206291223 type Work @default.
• W4206291223 citedByCount "3" @default.
• W4206291223 countsByYear W42062912232023 @default.
• W4206291223 crossrefType "journal-article" @default.
• W4206291223 hasAuthorship W4206291223A5006530180 @default.
• W4206291223 hasAuthorship W4206291223A5024977714 @default.
• W4206291223 hasAuthorship W4206291223A5032441791 @default.
• W4206291223 hasAuthorship W4206291223A5036795263 @default.
• W4206291223 hasAuthorship W4206291223A5044436273 @default.
• W4206291223 hasAuthorship W4206291223A5056794307 @default.

• next